Association of metabolic syndrome and its components with quality of life indicators in men with arterial hypertension
Metabolic syndrome (MS), by definition, is not a disease, but is a combination of individual metabolic risk factors, including abdominal obesity, hyperglycemia, hypertriglyceridemia, arterial hypertension (AH), and low high-density lipoprotein cholesterol, which in turn can dramatically increase the prevalence of type II diabetes and cardiovascular disease. The prevalence of MS varies greatly depending on the definition used, sex, age, socioeconomic status, and ethnicity of the study groups. Aim. To study the association of MS and its components with quality of life (QOL) indicators in men with AH. Materials and methods. 172 men with AH were examined, 106 of whom had MS. MS was diagnosed based on the criteria of clinical recommendations of the All-Russian Scientific Society of Cardiology in 2009. The assessment and the degree of QOL reduction were carried out using the methodology developed by A.G. Gladkov et al. (1982) and adapted by T.A. Ayvazyan et al. (1989). Results. Among the examined men with AH, having MS, QOL indicators of varying degrees of decrease were found in more than 80% of the surveyed. A decrease in QOL in men with MS was more often observed in individuals with a 4-component combination of MS components. The most frequent clusters of MS among men with different levels of QOL reduction were 3-, 4- and 5-component combinations, including abdominal obesity, AH and dyslipidemic disorders. More often, the decrease in QOL indicators in men with MS was influenced by such reasons as a decrease in activity in daily life, the need for treatment, restriction in nutrition and restriction of oneself in anything. Conclusion. It was found that in men with AH, the MS was largely associated with low QOL indicators.
Authors
- Olga L. Moskalenko (ORCID: https://orcid.org/0000-0003-4268-6568)
- Roman A. Yaskevich (ORCID: https://orcid.org/0000-0003-4033-3697)
- Evgeny L. Davydov
Publication Details
- Journal
- Clinical review for general practice
- Published
- 2025-05-26
- DOI
- https://doi.org/10.47407/kr2025.6.5.00611
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00